| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |